Amy Adelberger,
Founder and CEO,
Global Impact Advisors
Amy founded and leads Global Impact Advisors, a boutique strategy and evaluation advisory firm, where she is responsible for all aspects of the business including strategic direction, client engagement, and project delivery. She advises foundations, non-profits, and universities on achieving their program outcomes and enhancing their impact.
Her experience includes development of strategic plans, including setting organization, portfolio, and program level direction, as well as assessing progress through a variety of methods. She regularly leads multi-disciplinary teams that conduct stakeholder analyses, capabilities assessments, and process evaluations. She also engages with a range of funders in global health, including both private foundations and public sector donors.
Prior to founding GIA, Amy was a Program Officer in Global Health at the Bill & Melinda Gates Foundation. She managed an end-to-end program strategy, which included a focus on discovery, development, and delivery of Tuberculosis drugs, diagnostics, and vaccines. Amy received a BA in History from Brown University and an MPH from the University of Washington.
|
|
Perspectives on Developing a POC Diagnostic For Global HealthTuesday, 2 October 2018 at 16:58  Add to Calendar ▼2018-10-02 17:00:002018-10-02 18:00:00Europe/LondonPerspectives on Developing a POC Diagnostic For Global HealthPoint-of-Care Diagnostics and Global Health 2018 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.comThe aim of the panel is to discuss the challenges and opportunities in developing POC Dx for global health applications. This will be a panel discussion. Our panelists will share their perspectives on what it takes to succeed or fail developing POC diagnostics for global health applications as well as insights about funding global health POC diagnostics.
|
